Financials

News Ideas Technicals Forecast

603520 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to ZHEJIANG STARRY PHARMACEUTICAL CO.,LTD operating, investing, and financing activities

603520 free cash flow for Q3 23 is 46.38 M CNY. For 2022, 603520 free cash flow was -550.47 M CNY and operating cash flow was -78.29 M CNY.

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: CNY

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—